Scientific Review Committee

The Stanford Cancer Institute (SCI) Scientific Review Committee (SRC) is responsible for evaluating the scientific merit and progress of The Stanford Cancer Institute (SCI) Scientific Review Committee (SRC) is responsible for evaluating the scientific merit and progress of all human subject research trials involving cancer patients treated at Lucile Packard Children's Hospital, Stanford Hospital and Clinics, including network sites, as well as all cancer-relevant clinical trials that are not reviewed through an approved external peer review process. The primary focus of scientific review is on the scientific merit, feasibility, and utilization of resources.

Studies Requiring SRC Review

SRC review is a requirement of the National Cancer Institute (NCI) as part of the Stanford Cancer Institute’s comprehensive cancer center designation. 

Scientific review is required for all hypothesis driven cancer-related clinical research including interventional and non-interventional studies conducted by Stanford investigators.

Cancer related research includes study of participants with a cancer diagnosis, cancer prevention, cancer screening and survivorship.

SRC Review Process Overview

Protocol prioritization utilizes a two-stage process for selecting and prioritizing cancer clinical trials at SCI

Stage 1 – Review by Clinical Research Groups (CRGs)

Stage 2 – Review by SCI SRC

SRC Submission Process